Zentek Ltd. (NASDAQ:ZTEK - Get Free Report)'s share price traded up 2.3% during trading on Monday . The stock traded as high as $0.90 and last traded at $0.88. 50,934 shares were traded during trading, an increase of 20% from the average session volume of 42,498 shares. The stock had previously closed at $0.86.
Zentek Trading Up 4.9%
The company has a quick ratio of 1.00, a current ratio of 1.25 and a debt-to-equity ratio of 0.01. The company has a market cap of $96.69 million, a price-to-earnings ratio of -15.39 and a beta of 0.46. The company's fifty day moving average price is $1.34 and its two-hundred day moving average price is $1.20.
Zentek (NASDAQ:ZTEK - Get Free Report) last announced its quarterly earnings results on Thursday, June 26th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.57 million for the quarter. Zentek had a negative return on equity of 58.87% and a negative net margin of 1,186.72%.
Institutional Trading of Zentek
Several hedge funds and other institutional investors have recently modified their holdings of ZTEK. Scotia Capital Inc. lifted its stake in Zentek by 5.7% in the 4th quarter. Scotia Capital Inc. now owns 958,771 shares of the company's stock valued at $867,000 after purchasing an additional 51,744 shares during the last quarter. Two Sigma Securities LLC bought a new position in shares of Zentek during the fourth quarter valued at $31,000. Finally, Anson Funds Management LP bought a new position in shares of Zentek during the fourth quarter valued at $145,000. Institutional investors own 0.77% of the company's stock.
Zentek Company Profile
(
Get Free Report)
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.
Further Reading
Before you consider Zentek, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zentek wasn't on the list.
While Zentek currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
